Log In
BCIQ
Print this Print this
 

RBX7455

  Manage Alerts
Collapse Summary General Information
Company Rebiotix Inc.
DescriptionBroad-spectrum microbiota drug
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationClostridium
Indication DetailsPrevent Clostridium difficile infection (CDI)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today